Reusable snorkel masks adapted as particulate respirators.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 08 09 2020
accepted: 13 03 2021
entrez: 5 4 2021
pubmed: 6 4 2021
medline: 14 4 2021
Statut: epublish

Résumé

During viral pandemics, filtering facepiece (FFP) masks together with eye protection form the essential components of personal protective equipment (PPE) for healthcare workers. There remain concerns regarding insufficient global supply and imperfect protection offered by currently available PPE strategies. A range of full-face snorkel masks were adapted to accept high grade medical respiratory filters using bespoke-designed 3D-printed connectors. We compared the protection offered by the snorkel to that of standard PPE using a placebo-controlled respirator filtering test as well as a fluorescent droplet deposition experiment. Out of the 56 subjects tested, 42 (75%) passed filtering testing with the snorkel mask compared to 31 (55%) with a FFP3 respirator mask (p = 0.003). Amongst the 43 subjects who were not excluded following a placebo control, 85% passed filtering testing with the snorkel versus to 68% with a FFP3 mask (p = 0.008). Following front and lateral spray of fluorescence liquid particles, the snorkel mask also provided superior protection against droplet deposition within the subject's face, when compared to a standard PPE combination of FFP3 masks and eye protection (3.19x108 versus 6.81x108 fluorescence units, p<0.001). The 3D printable adaptors are available for free download online at https://www.ImperialHackspace.com/COVID-19-Snorkel-Respirator-Project/. Full-face snorkel masks adapted as particulate respirators performed better than a standard PPE combination of FFP3 mask and eye protection against aerosol inhalation and droplet deposition. This adaptation is therefore a promising PPE solution for healthcare workers during highly contagious viral outbreaks.

Identifiants

pubmed: 33819279
doi: 10.1371/journal.pone.0249201
pii: PONE-D-20-28261
pmc: PMC8021169
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0249201

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

No authors have competing interests.

Références

Viruses. 2019 Oct 12;11(10):
pubmed: 31614743
Med Mal Infect. 2012 Jun;42(6):264-9
pubmed: 22683102
J R Soc Interface. 2009 Dec 6;6 Suppl 6:S783-90
pubmed: 19773292
J Hosp Infect. 2021 Apr;110:89-96
pubmed: 33453351
JAMA Netw Open. 2020 Jul 1;3(7):e2016924
pubmed: 32725247
BMJ. 2020 Aug 20;370:m3206
pubmed: 32819961
Anaesthesia. 2020 Jul;75(7):970-971
pubmed: 32275770
Ophthalmology. 2020 Oct;127(10):1427-1429
pubmed: 32574762
Int J Environ Res Public Health. 2020 Jun 19;17(12):
pubmed: 32575366
World Dev. 2021 Mar;139:105324
pubmed: 33293754
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Healthc Infect. 2012 Dec;17(4):111-114
pubmed: 32288839
MRS Bull. 2020;45(10):794-796
pubmed: 33437116
PLoS One. 2021 Jan 13;16(1):e0244422
pubmed: 33439902
Crit Care Resusc. 2010 Mar;12(1):24-7
pubmed: 20196710
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512

Auteurs

Henry Seligman (H)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.

Sameer Zaman (S)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.

David S Pitcher (DS)

Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.
Advanced Hackspace, Imperial College London, London, United Kingdom.

Matthew J Shun-Shin (MJ)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.

Freya Hepworth Lloyd (F)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.

Vitaliy Androschuk (V)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.

Sayan Sen (S)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.

Rasha Al-Lamee (R)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.

David M Miller (DM)

Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.
Advanced Hackspace, Imperial College London, London, United Kingdom.

Harry W Barnett (HW)

Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.
Advanced Hackspace, Imperial College London, London, United Kingdom.

Gulam S Haji (GS)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.

Luke S Howard (LS)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.

Sukhjinder Nijjer (S)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.

Jamil Mayet (J)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.

Darrel P Francis (DP)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.

Oscar Ces (O)

Advanced Hackspace, Imperial College London, London, United Kingdom.
Department of Chemistry, Imperial College London, London, United Kingdom.

Nicholas W F Linton (NWF)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.

Nicholas S Peters (NS)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.

Ricardo Petraco (R)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Imperial Centre for Cardiac Engineering, Imperial College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH